You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

edoxaban

Showing 26 - 50 of 208
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

New Oral Anticoagulants in Treatment of Non-valvular Atrial

Recruiting
  • Atrial Fibrillation
  • Burgos, Spain
  • +5 more
Jan 2, 2023

Direct Oral AntiCoagulants and Ticagrelor Study II

Not yet recruiting
  • Novel Oral Anticoagulants
  • +11 more
  • Detection of genotype and RNA profile in platelet and white blood cell
  • +2 more
  • Hefei, Anhui, China
  • +5 more
Mar 1, 2023

Myocardial Infarction Type 2 Trial (Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic

Not yet recruiting
  • Myocardial Infarction Type 2
  • Coronary computed tomography angiography
  • +7 more
  • (no location specified)
Jun 15, 2022

Anticoagulants in Patients With Venous Thromboembolism in Korea

Completed
  • Venous Thromboembolism
  • Parenteral anticoagulant
  • +5 more
  • Seongnam-si, Korea, Republic of
  • +1 more
May 20, 2022

Atrial Fibrillation Trial in Italy (Edoxaban)

Completed
  • Atrial Fibrillation
  • Edoxaban
  • San Benedetto Del Tronto, Ascoli Piceno, Italy
  • +7 more
May 1, 2021

Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey

Active, not recruiting
  • Atrial Fibrillation
  • Edoxaban
  • Antalya, Alanya, Turkey
  • +44 more
May 18, 2022

Aortic Stenosis Trial in Oslo (Acetylsalicylic acid, Apixaban, Rivaroxaban)

Recruiting
  • Aortic Stenosis
  • Acetylsalicylic acid
  • +3 more
  • Oslo, Norway
  • +1 more
Mar 23, 2022

Healthy Trial in South Miami, Secaucus, San Antonio (Ciraparantag, Placebo, Point-of-Care Coagulometer (investigational device))

Recruiting
  • Healthy
  • South Miami, Florida
  • +2 more
Feb 18, 2022

Left Atrial Appendage Closure, Thrombosis, Stroke Trial in Quebec (Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel

Recruiting
  • Left Atrial Appendage Closure
  • +4 more
  • Rivaroxaban, dabigatran, apixaban, or edoxaban
  • +2 more
  • Quebec, Canada
    Josep Rodes-Cabau
Jul 12, 2022

The DARE Warfarin CER Study

Enrolling by invitation
  • Deep Venous Thrombosis
  • Pulmonary Embolism
  • Dabigatran: extended treatment (e.g at least 90 days)
  • +14 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 17, 2021

Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral

Completed
Has Results
  • Venous Thrombosis
  • Neoplasms
  • Heparin, Low-Molecular-Weight, or direct oral anticoagulants
  • Minneapolis, Minnesota
  • +2 more
Apr 26, 2022

Deep Vein Thrombosis, Venous Thromboembolism Trial in Worldwide (Edoxaban low dose, Edoxaban high dose)

Completed
  • Deep Vein Thrombosis
  • Venous Thromboembolism
  • Edoxaban low dose
  • Edoxaban high dose
  • Los Angeles, California
  • +34 more
Jan 18, 2022

Cardiac Disease Trial in Worldwide (Edoxaban, Standard of Care (SOC))

Completed
Has Results
  • Cardiac Disease
  • Edoxaban
  • Standard of Care (SOC)
  • Birmingham, Alabama
  • +47 more
Jul 5, 2022

NOACs in Oral and Maxillofacial Surgery: Impact on

Recruiting
  • Surgery, Oral
  • +5 more
  • Type of surgery
  • +5 more
  • Helsingborg, Sweden
  • +1 more
Apr 11, 2022

Atrial High Rate Episodes Trial in Multiple Locations (Edoxaban, ASA)

Recruiting
  • Atrial High Rate Episodes
  • Multiple Locations, Austria
  • +16 more
Jun 3, 2022

Heavy Menstrual Bleeding Trial in Frankfurt am Main (Apixaban 5 MG, Rivaroxaban 20 MG, Edoxaban 60 MG)

Recruiting
  • Heavy Menstrual Bleeding
  • Apixaban 5 MG
  • +3 more
  • Frankfurt am Main, Germany
    Cardioangiology Center Bethanien (CCB)
Dec 29, 2021

Acute Ischemic Stroke Trial in Seoul (Edoxaban)

Completed
  • Acute Ischemic Stroke
  • Edoxaban
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 9, 2020

Precision Medicine Platform for Novel Oral Anticoagulants

Recruiting
  • Anticoagulant Adverse Reaction
  • Pharmacogenomics
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Aug 30, 2021

Atrial Fibrillation Trial (Non-vitamin K oral anticoagulants (NOACs), Warfarin)

Not yet recruiting
  • Atrial Fibrillation
  • Non-vitamin K oral anticoagulants (NOACs)
  • Warfarin
  • (no location specified)
Aug 6, 2021

Direct Oral Anticoagulants in UK Clinical Practice ForFirst

Completed
  • Atrial Fibrillation
  • Edoxaban
  • +2 more
  • Glasgow, United Kingdom
  • +7 more
Jul 15, 2022

Anticoagulants; Increased Trial (Apixaban)

Not yet recruiting
  • Anticoagulants; Increased
  • (no location specified)
May 14, 2021

Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)

Recruiting
  • Coagulation Disorder
  • Groningen, Netherlands
    QPS Netherlands B.V.
Dec 7, 2021

Aortic Valve Stenosis Trial in Hong Kong, Korea, Republic of, Taiwan (NOAC, DAPT)

Completed
  • Aortic Valve Stenosis
  • Hong Kong, Hong Kong
  • +4 more
Nov 5, 2021

Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Seoul (Edoxaban, Warfarin)

Completed
  • Atrial Fibrillation
  • Anticoagulants and Bleeding Disorders
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 31, 2020

Anticoagulation Reversal Trial in Overland Park (PER977, Placebo, Edoxaban)

Completed
  • Anticoagulation Reversal
  • Overland Park, Kansas
    Quintiles
May 19, 2020